SCHEMBL2962342

SCHEMBL2962342

COc1ccc(C(=O)c2ccc(OC)cc2Cc2ccccc2)c(Cc2ccccc2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 1/20 0.58
MTNR1B P49286 1/20 0.58
ALDH1A1 P00352 3/20 0.57
CYP1A2 P05177 3/20 0.55
CYP2C19 P33261 3/20 0.55
LMNA P02545 2/20 0.55
PGR P06401 2/20 0.55
HPGD P15428 2/20 0.55
SLC6A2 P23975 2/20 0.55
CYP2D6 P10635 2/20 0.55
PDE4A P27815 1/20 0.55
MAPK1 P28482 1/20 0.55
HRH1 P35367 1/20 0.55
HTT P42858 1/20 0.55
SLC6A3 Q01959 1/20 0.55
PDE4D Q08499 1/20 0.55
CYP3A4 P08684 2/20 0.53
HIF1A Q16665 2/20 0.53
ADORA3 P0DMS8 1/20 0.53
AR P10275 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3098374 0.91 MTNR1A (0.58) MTNR1AMTNR1BALDH1A1CYP1A2CYP2C19
SCHEMBL10339877 0.90 NPC1 (0.54) MTNR1AMTNR1BALDH1A1CYP1A2CYP2C19
SCHEMBL28208639 0.88 MTNR1A (0.59) MTNR1AMTNR1BALDH1A1CYP1A2CYP2C19
SCHEMBL28357410 0.88 MTNR1A (0.55) MTNR1AMTNR1BALDH1A1CYP1A2CYP2C19
SCHEMBL2900959 0.87 ALDH1A1 (0.60) MTNR1AMTNR1BALDH1A1CYP1A2CYP2C19
SCHEMBL7855639 0.85 LMNA (0.49) MTNR1AMTNR1BALDH1A1CYP1A2CYP2C19
SCHEMBL27855822 0.84 MTNR1A (0.52) MTNR1AMTNR1BALDH1A1CYP1A2CYP2C19
SCHEMBL10339878 0.84 MAPT (0.49) ALDH1A1CYP1A2HPGDMAPK1ALOX15
SCHEMBL3102721 0.83 MTNR1A (0.57) MTNR1AMTNR1BALDH1A1HPGDHTT
SCHEMBL7591665 0.83 SMN1; SMN2 (0.51) MTNR1AMTNR1BALDH1A1LTA4HNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776867-B2 Furanopyrimidines AMGEN INC. (US) 2010-08-17 US disclosed
EP-1768986-A2 FURANOPYRIMIDINES Amgen Inc. (US) 2007-04-04 EP disclosed
US-20060040961-A1 Furanopyrimidines AMGEN INC. 2006-02-23 US disclosed
WO-2006004658-A2 FURANOPYRIMIDINES AMGEN INC. (US) 2006-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060040961-A1 Furanopyrimidines TYMS, IDO1, NFATC1 MTNR1A 488/4885MTNR1B 1792/4885ALDH1A1 159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.